In vitrometabolism of the specific endothelin-A receptor antagonist ZD4054 and clinical drug interactions between ZD4054 and rifampicin or itraconazole in healthy male volunteers-Reference-Cited by-同舟云学术

In vitrometabolism of the specific endothelin-A receptor antagonist ZD4054 and clinical drug interactions between ZD4054 and rifampicin or itraconazole in healthy male volunteers

Published:2009-03-12 Issue:6 Volume:39 Page:444-456
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Swaisland H. C.,Oliver S. D.,Morris T.,Jones H. K.,Bakhtyari A.,Mackey A.,McCormick A. D.,Slamon D.,Hargreaves J. A.,Millar A.,Taboada M. T.

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/00498250902810944

Reference23 articles.

1. Lack of Effect of Antimycotic Itraconazole on the Pharmacokinetics or Pharmacodynamics of Temazepam

2. The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin

3. Lack of Enzyme-Inducing Effect of Rifampicin on the Pharmacokinetics of Enfuvirtide

4. Atrasentan, an Endothelin-Receptor Antagonist for Refractory Adenocarcinomas: Safety and Pharmacokinetics

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and Tolerability of Zibotentan in Patients with Concurrent Moderate Renal and Moderate Hepatic Impairment;Clinical Pharmacokinetics;2023-10-06

2. Zibotentan;Handbook of Metabolic Pathways of Xenobiotics;2013-10-13

3. Single- and multiple-dose pharmacokinetics, safety and tolerability of zibotentan (ZD4054) in Chinese men with advanced solid tumors;Cancer Chemotherapy and Pharmacology;2012-05-22

4. Disposition and metabolism of the specific endothelin A receptor antagonist zibotentan (ZD4054) in healthy volunteers;Xenobiotica;2011-10-20

5. The metabolism of [14C]-zibotentan (ZD4054) in rat, dog and human, the loss of the radiolabel and the identification of an anomalous peak, derived from the animal feed;Journal of Pharmaceutical and Biomedical Analysis;2011-06